
Investigation of Arqit Quantum Inc. f/k/a Centricus Acquisition Corp.
Arqit Quantum Inc. (ARQQ) Made Misleading Statements in its Offering Documents in Support of its Merger with Centricus Acquisition Corp. (CENH) A shareholder filed a
Arqit Quantum Inc. (ARQQ) Made Misleading Statements in its Offering Documents in Support of its Merger with Centricus Acquisition Corp. (CENH) A shareholder filed a
Okta, Inc. (OKTA) Failed to Disclose Security Breach A shareholder filed a class action on behalf of all persons and entities that purchased or
Enservco Corporation (ENSV) Delays Filing its Year End and Quarterly Reports Due to Accounting Errors A shareholder filed a class action on behalf of all
Pegasystems, Inc. (PEGA) found guilty of stealing its competitor’s trade secrets A shareholder filed a class action on behalf of all persons and entities that
HUMBL, Inc. (HMBL) Misled Investors Regarding its Business Prospects A shareholder filed a class action on behalf of all persons and entities that purchased or
Dentsply Sirona Inc. (XRAY) is at risk of losing NASDAQ Listing Eligibility Robbins LLP is investigating Dentsply Sirona Inc. (NASDAQ: XRAY) and its officers and directors
Robbins LLP Investigates Progyny, Inc. (PGNY) on Behalf of Shareholders Robbins LLP is investigating Progyny, Inc. (NASDAQ: PGNY) to determine whether certain Progyny officers and
Robbins LLP Investigates Butterfly Network, Inc. (BFLY) on Behalf of Shareholders Robbins LLP is investigating Butterfly Network, Inc. (NYSE: BFLY) to determine whether certain Butterfly
Axsome Therapeutics, Inc. (AXSM) Made Misleading Statements in Connection with its New Drug Application for AXS-07 for the Acute Treatment of Migraine A shareholder
Attorney Advertising. Past results do not guarantee a similar outcome.
Disclaimer | Site Map | Privacy Policy
© 2021 – Robbins LLP